Resveratrol and cancer: A review

Biomedicine and Pharmacotherapy

Volumn 56, Issue 2, 2002, Pages 84-87

  Savouret, J F ^a   Quesne, M ^a  

^a BICÊTRE HOSPITAL   (France)

Author keywords

Aryl hydrocarbon receptor; Chemoprevention; Resveratrol

Indexed keywords

ANTINEOPLASTIC AGENT; CARCINOGEN; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; CYTOCHROME P450; CYTOCHROME P450 1A1; CYTOCHROME P450 1A2; CYTOCHROME P450 1B1; FLAVONOID; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; POLYPHENOL DERIVATIVE; RESVERATROL;

ANTINEOPLASTIC ACTIVITY; CANCER CHEMOTHERAPY; CANCER GROWTH; CANCER PREVENTION; CARCINOGENESIS; CELL PROLIFERATION; CHEMOPROPHYLAXIS; DETOXIFICATION; DRUG CYTOTOXICITY; DRUG EFFECT; DRUG MECHANISM; ENZYME ACTIVITY; ENZYME INHIBITION; ESTROGEN ACTIVITY; HUMAN; PRIORITY JOURNAL; REVIEW; XENOBIOTIC METABOLISM;

EID: 0036130279     PISSN: 07533322     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0753-3322(01)00158-5     Document Type: Article

References (39)

1. Chemical constituents of polygonaceous plants. I. Studies on the components of Ko-jo-kon (Polygonum Cuspidatum SIEB et ZUCC)
2. Cancer chemopreventive activity of resveratrol, a natural product derived from grapes
3. Biological effects of resveratrol
4. A reappraisal of the potential chemopreventive and chemotherapeutic properties of resveratrol
5. The production of resveratrol by Vitis Vinifera and other members of the Vitaceae as a response to infection or injury
6. Concentration of the Phytoalexin resveratrol in wine
7. Coronary risk factors. The French paradox
8. Wine, alcohol, platelets, and the French paradox for coronary heart disease
9. Does diet or alcohol explain the French paradox?
10. Cancer, cigarette smoking and premature death in Europe: A review including the Recommendations of European Cancer Experts Consensus Meeting, Helsinki, October 1996
11. Exposure to polychlorinated dioxins and furans (PCDD/F) and mortality in a cohort of workers from a herbicide-producing plant in Hamburg, Federal Republic of Germany
12. Dioxin exposure and cancer risk: A 15-year mortality study after the "Seveso accident"
13. Induction of cytochrome P4501A1 by 2,3,7,8-tetrachlorodibenzo-p-dioxin or indolo(3,2-b)carbazole is associated with oxidative DNA damage
14. Resveratrol has antagonist activity on the aryl hydrocarbon receptor: Implications for prevention of dioxin toxicity
15. Resveratrol inhibits transcription of CYP1A1 in vitro by preventing activation of the aryl hydrocarbon receptor
16. Inhibition of aryl hydrocarbon-induced cytochrome P-450 1A1 enzyme activity and CYP1A1 expression by resveratrol
17. Chemoprevention by inducers of carcinogen detoxication enzymes
18. Resveratrol inhibits cyclooxygenase-2 transcription and activity in phorbol ester-treated human mammary epithelial cells
19. Resveratrol prevents apoptosis in K562 cells by inhibiting lipoxygenase and cyclooxygenase activity
20. Chronic immune activation and inflammation as the cause of malignancy
21. Chemopreventive properties of trans-resveratrol are associated with inhibition of activation of the IkappaB kinase
22. Protein-tyrosine kinase inhibition: Mechanism-based discovery of antitumor agents
23. Cancer chemopreventive activity of resveratrol
24. Resveratrol, a natural product present in wine, decreases tumour growth in a rat tumour model
25. Chemopreventive agent resveratrol, a natural product derived from grapes, reversibly inhibits progression through S and G2 phases of the cell cycle in U937 cells
26. Resveratrol, a polyphenolic compound found in grapes and wine, is an agonist for the estrogen receptor
27. Resveratrol analog, 3,4,5,4'-tetrahydroxystilbene, differentially induces pro-apoptotic p53/Bax gene expression and inhibits the growth of transformed cells but not their normal counterparts
28. Resveratrol, a natural product derived from grape, exhibits antiestrogenic activity and inhibits the growth of human breast cancer cells
29. Resveratrol acts as a mixed agonist/antagonist for estrogen receptors alpha and beta
30. Resveratrol exhibits cytostatic and antiestrogenic properties with human endometrial adenocarcinoma (Ishikawa) cells
31. 4-Hydroxylation of estradiol by human uterine myometrium and myoma microsomes: Implications for the mechanism of uterine tumorigenesis
32. Anti-genotoxicity of galangin as a cancer chemopreventive agent candidate
33. Cancer chemoprevention and apoptosis mechanisms induced by dietary polyphenolics
34. High intake of specific carotenoids and flavonoids does not reduce the risk of bladder cancer
35. Estrogen receptor alpha mediates the proliferative but not the cytotoxic dose-dependent effects of two major phytoestrogens on human breast cancer cells
36. Alpha-Naphthoflavone-induced Cyp1a1 gene expression and cytosolic aryl hydrocarbon receptor transformation
37. Agonistic and antagonistic effects of alpha-naphthoflavone on dioxin receptor function. Role of the basic region helix-loop-helix dioxin receptor partner factor Arnt
38. Quercetin increases the severity of estradiol-induced tumorigenesis in hamster kidney
39. Lipid peroxidation and DNA damage induced by morin and naringenin in isolated rat liver nuclei